Nine independent modeling teams demonstrate that maintaining a universal COVID-19 vaccine policy yields consistent population-level benefits, reducing hospitalizations…
TOPLINE: In a meta-analysis assessing first-line treatment options for advanced hepatocellular carcinoma (HCC), atezolizumab plus bevacizumab demonstrated the…